An Open Label, Pilot Study of Dose-Dense Adriamycin [doxorubicin] Plus Cyclophosphamide (AC) Followed by ABI-007 [Abraxane, paclitaxel] as Adjuvant Therapy for Patients With Breast Cancer.
Phase of Trial: Phase I
Latest Information Update: 19 Jul 2007
At a glance
- Drugs Cyclophosphamide; Doxorubicin; Paclitaxel
- Indications Early breast cancer
- Focus Adverse reactions
- 19 Jul 2007 Status changed from in progress to completed.
- 24 Sep 2005 New trial record.